Company intelligence / Profile preview
Hunan Changde Sanjin Pharmaceutical
Changde, Hunan, Chinasanjin.com.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company manufactures a broad range of proprietary traditional Chinese medicines with over-the-counter approval status. Its affiliate network has entered clinical development of monoclonal antibodies through external partnerships. For example, the herbal formula "Yuye Jiedu Granule" has demonstrated concerted inhibition of mTORC1/2 and NF-kappaB pathways in preclinical studies.
- Therapeutic areas
- OtherPulmonologyOncologyInfectious Diseases
- Modalities
- Herbal medicineSmall moleculeMonoclonal antibody
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Adagene for monoclonal antibodies developmentpossible internal supply chain links to Dragonboat Biopharmaceutical
Beyond the preview
Go deeper on Hunan Changde Sanjin Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hunan Changde Sanjin Pharmaceutical.